CH534878A - Verfahren zur Bestimmung der Anwesenheit von gegen bestimmte Allergene gerichteten Reagin-Immunoglobulinen (Reagin-Ig) in wässrigen Proben - Google Patents

Verfahren zur Bestimmung der Anwesenheit von gegen bestimmte Allergene gerichteten Reagin-Immunoglobulinen (Reagin-Ig) in wässrigen Proben

Info

Publication number
CH534878A
CH534878A CH1313868A CH1313868A CH534878A CH 534878 A CH534878 A CH 534878A CH 1313868 A CH1313868 A CH 1313868A CH 1313868 A CH1313868 A CH 1313868A CH 534878 A CH534878 A CH 534878A
Authority
CH
Switzerland
Prior art keywords
reagin
immunoglobulins
determining
directed against
against certain
Prior art date
Application number
CH1313868A
Other languages
English (en)
Inventor
H Son Bennich Hans
Olof Johansson Stig Gunnar
Edvin Wide Leif
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to CH115171A priority Critical patent/CH551010A/de
Priority to CH115071A priority patent/CH551009A/de
Publication of CH534878A publication Critical patent/CH534878A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1015—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1078—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being against an immunoglobulin, i.e. being an (anti)-anti-idiotypic antibody
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Optics & Photonics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CH1313868A 1967-09-06 1968-09-02 Verfahren zur Bestimmung der Anwesenheit von gegen bestimmte Allergene gerichteten Reagin-Immunoglobulinen (Reagin-Ig) in wässrigen Proben CH534878A (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CH115171A CH551010A (de) 1967-09-06 1968-09-02 Verfahren zur herstellung eines markierten reagin-immunoglobulins.
CH115071A CH551009A (de) 1967-09-06 1968-09-02 Verfahren zur herstellung markierter antikoerper gegen reagin-immunoglobuline.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE1229767A SE341239B (de) 1967-09-06 1967-09-06

Publications (1)

Publication Number Publication Date
CH534878A true CH534878A (de) 1973-03-15

Family

ID=20295495

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1313868A CH534878A (de) 1967-09-06 1968-09-02 Verfahren zur Bestimmung der Anwesenheit von gegen bestimmte Allergene gerichteten Reagin-Immunoglobulinen (Reagin-Ig) in wässrigen Proben

Country Status (13)

Country Link
JP (1) JPS50892B1 (de)
AT (2) AT295744B (de)
BE (1) BE720341A (de)
CH (1) CH534878A (de)
CS (1) CS191857B2 (de)
DK (1) DK131400B (de)
ES (1) ES357863A1 (de)
FI (1) FI48785C (de)
FR (1) FR1588874A (de)
GB (1) GB1248764A (de)
NL (1) NL162209C (de)
NO (2) NO127685B (de)
SE (1) SE341239B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) * 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
USRE31006E (en) * 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other
US3966897A (en) * 1973-04-02 1976-06-29 Marine Colloids, Inc. Medium for use in bioassay and method of using same
US4041146A (en) * 1975-05-01 1977-08-09 General Electric Company Method for detection of biological particles
GB1555142A (en) * 1975-08-14 1979-11-07 Sinai School Medicine Blood cell typing and compatibility test procedure
AT343822B (de) * 1976-08-20 1978-06-26 Immuno Ag Radioimmunologisches verfahren und einrichtung zur bestimmung von antigenen
US4289748A (en) * 1979-05-31 1981-09-15 United States Of America Ultrasensitive enzymatic radioimmunoassay method
FR2502786B1 (fr) * 1981-03-24 1985-06-21 Stallergenes Laboratoire Procede de fixation d'antigenes et d'anticorps sur support de polysaccharides, et utilisation du produit ainsi obtenu pour les dosages immunologiques
US4481298A (en) * 1981-04-13 1984-11-06 Amf Incorporated Pre-precipitated double antibody immunoassay method
NL8102178A (nl) * 1981-05-02 1982-12-01 Stichting Centraal Lab Werkwijze voor het aantonen van tegen bepaalde antigenen gerichte antistoffen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze.
JPS6199195U (de) * 1984-11-30 1986-06-25

Also Published As

Publication number Publication date
NO138182B (no) 1978-04-10
JPS50892B1 (de) 1975-01-13
DK131400B (da) 1975-07-07
NO127685B (de) 1973-07-30
DE1798170B1 (de) 1972-04-27
NL6812559A (de) 1969-03-10
AT288593B (de) 1971-03-10
SE341239B (de) 1971-12-20
BE720341A (de) 1969-02-17
ES357863A1 (es) 1970-04-01
GB1248764A (en) 1971-10-06
NL162209B (nl) 1979-11-15
NO138182C (no) 1978-07-26
FR1588874A (de) 1970-03-16
DK131400C (de) 1975-11-24
NL162209C (nl) 1980-04-15
FI48785C (fi) 1974-12-10
AT295744B (de) 1972-01-10
CS191857B2 (en) 1979-07-31
FI48785B (de) 1974-09-02

Similar Documents

Publication Publication Date Title
DE1668993B2 (de) Verfahren zur isolierung von alpha-glycolid
CH534878A (de) Verfahren zur Bestimmung der Anwesenheit von gegen bestimmte Allergene gerichteten Reagin-Immunoglobulinen (Reagin-Ig) in wässrigen Proben
CH472840A (de) Verfahren zur Gewinnung von Protein
CH460656A (de) Verfahren zur Vernichtung von Ölemulsionen
AT301224B (de) Verfahren zur Bestimmung der Zusammensetzung von Legierungen
AT279804B (de) Verfahren zur Isolierung von Antigenen und Antikörpern
CH497482A (de) Verfahren und Vorrichtung zur Herstellung von Polyamiden
CH532031A (de) Verfahren zur Herstellung von in 2-Stellung substituierten 5-Nitro-furan-, 5-Nitro-thiophen- und 5-Nitro-pyrrolderivaten
AT301244B (de) Verfahren zur Bekämpfung von Helminthiasis bei Haustieren
CH503042A (de) Verfahren zur Herstellung von Piperidin-spiro-heterocyclen
AT264160B (de) Verfahren und Vorrichtung zur Bestimmung der Durchlässigkeit von Feststoffproben
AT286243B (de) Verfahren zur quantitativen Bestimmung von Vitamin B12
CH525173A (de) Verfahren zur Herstellung von 3-Methylbut-2-en-1-ol oder 3-Methylbut-2-en-1-ylacetat
AT285539B (de) Verfahren und Einrichtung zur chromatographischen Trennung von Aminosäuregemischen
CH500716A (de) Verfahren zur Gewinnung von Antikörpern
AT302812B (de) Verfahren zur elektrophoretischen Bilderzeugung
AT293850B (de) Verfahren zur konservierung von nahrungsmitteln
CH499521A (de) Verfahren zur Bestimmung von Kreatinin und Farbreagens dafür
AT278001B (de) Verfahren zur Herstellung von N-Trityl-imidazolen
AT287745B (de) Verfahren zur herstellung von durchschreibematerialien
AT281420B (de) Verfahren zur Herstellung von α-Triorganosiloxy-ω-hydroxy-diorganopolysiloxanen
CH449416A (de) Verfahren zur Steigerung der Empfindlichkeit von Halogensilberemulsionen
CH502983A (de) Verfahren zur Herstellung von Alkoxymethylenmalonaten
CH512522A (de) Verfahren zur Anreicherung von Proteinen
AT251311B (de) Verfahren und Vorrichtung zur Bestimmung der Dampffeuchtigkeit

Legal Events

Date Code Title Description
PL Patent ceased